Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-13 Sale |
2022-05-17 5:12 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
131,650 | $10.45 | $1,375,564 | 2,155,930 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:47 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
160,901 | $10.39 | $1,671,824 | 2,287,580 (Direct) |
View |
| 2022-05-05 Sale |
2022-05-09 6:58 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
86,677 | $10.37 | $898,921 | 2,448,481 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 7:30 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
270,675 | $10.38 | $2,809,332 | 2,535,158 (Direct) |
View |
| 2022-04-27 Sale |
2022-04-29 5:50 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
190,026 | $10.38 | $1,972,579 | 2,805,833 (Direct) |
View |
| 2022-04-22 Sale |
2022-04-26 6:40 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
129,781 | $10.39 | $1,347,796 | 2,995,859 (Direct) |
View |
| 2022-04-19 Sale |
2022-04-21 8:54 pm |
Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner |
547,734 | $10.41 | $5,700,491 | 3,125,640 (Direct) |
View |
| 2022-02-23 Sale |
2022-02-25 6:21 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Novo Holdings A/S 10% Owner |
8,110 | $2.8443 | $23,067 | 2,161,990 (Direct) |
View |
| 2021-06-18 Purchase |
2021-06-21 4:26 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
7,224 | $6.04 | $43,633 | 815,734 (Direct) |
View |
| 2021-06-16 Purchase |
2021-06-17 4:33 pm |
Checkmate Pharmaceuticals Inc. | CMPI | Krieg Arthur M Chief Scientific Officer |
3,578 | $6.18 | $22,112 | 808,510 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-04 Option Award |
2022-04-28 5:03 pm |
N/A 2031-03-03 |
Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer |
54,600 | $0 | 54,600 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 4:10 pm |
N/A 2032-03-01 |
Checkmate Pharmaceuticals Inc. | CMPI | BASH ALAN Chief Executive Officer |
575,000 | $0 | 575,000 (Direct) |
View |
| 2022-01-30 Option Award |
2022-02-01 4:25 pm |
N/A 2032-01-29 |
Checkmate Pharmaceuticals Inc. | CMPI | Wigginton Jon Marc Director |
20,061 | $0 | 20,061 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 4:05 pm |
N/A 2032-01-26 |
Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer |
101,180 | $0 | 101,180 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 4:05 pm |
N/A 2032-01-26 |
Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer |
101,180 | $0 | 101,180 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-17 8:22 pm |
N/A 2031-12-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Yan Joy Director |
20,061 | $0 | 20,061 (Direct) |
View |
| 2021-10-27 Option Award |
2021-10-29 6:54 pm |
N/A 2031-10-27 |
Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan See Remarks |
246,671 | $0 | 246,671 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:05 pm |
N/A 2031-08-09 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 4:05 pm |
N/A 2031-08-03 |
Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer |
27,300 | $0 | 27,300 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 4:05 pm |
N/A 2031-08-03 |
Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer |
27,300 | $0 | 27,300 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 4:05 pm |
N/A 2031-08-03 |
Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer |
27,300 | $0 | 27,300 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 4:05 pm |
N/A 2031-08-03 |
Checkmate Pharmaceuticals Inc. | CMPI | Labinger Barry President and CEO |
85,950 | $0 | 85,950 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:24 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Flaherty Keith T. Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:22 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:20 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Isacoff Oren Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:18 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | Colabuono Peter Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:18 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director |
10,030 | $0 | 10,030 (Direct) |
View |